Working to Eradicate Gynecologic Cancers

Jose Angel Arranz, MD

Doctor
Hospital General
123 Elm
Madrid Spain

Papers:
8 A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)